Jmac Enterprises LLC cut its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 10.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,559 shares of the company’s stock after selling 908 shares during the period. Jmac Enterprises LLC’s holdings in Colgate-Palmolive were worth $687,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in CL. Union Bancaire Privee UBP SA purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Hager Investment Management Services LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $36,000. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the third quarter worth $42,000. Synergy Asset Management LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at $49,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $53,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities analysts have weighed in on the company. UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. TD Cowen reduced their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.16.
Colgate-Palmolive Trading Up 1.6 %
Shares of Colgate-Palmolive stock opened at $87.35 on Wednesday. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The company has a fifty day simple moving average of $90.14 and a 200-day simple moving average of $96.69. The stock has a market cap of $71.37 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a 12-month low of $82.68 and a 12-month high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the business earned $0.87 EPS. On average, equities analysts forecast that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.29%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Broadcom Stock: Why the Upside Is Too Good to Ignore
- 3 Small Caps With Big Return Potential
- Citigroup Analysts Are Betting Big on These 3 Stocks—Should You?
- Why Are Stock Sectors Important to Successful Investing?
- Johnson Controls: 5 Reasons to Own This Engineering Giant
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.